Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest gabapentin Stories

2009-05-18 12:21:00

ORLANDO, May 18 /PRNewswire-USNewswire/ -- A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO). They say the agent, pregabalin, decreased hot flash severity and frequency about 20 percent more than did a placebo agent. Thus, pregabalin appears to offer about the same benefit as gabapentin, an older, related drug, as well as newer classes of antidepressants. "Hot flashes...

2009-05-15 09:38:15

 A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).They say the agent, pregabalin, decreased hot flash severity and frequency about 20 percent more than did a placebo agent. Thus, pregabalin appears to offer about the same benefit as gabapentin, an older, related drug, as well as newer classes of antidepressants."Hot flashes are a major problem in many women, and...

9e2ed01b1f60bac0647592f18bba85c5
2009-05-03 08:05:00

Due to manufacturing problems, India's largest drugmaker announced Saturday the recall of an antibiotic currently being sold in the United States.  The company has witnessed a huge setback as a result of the recall, the Associated Free Press accounted. The antibiotic capsules called nitrofurantoin, which is commonly used to treat urinary tract infections, was voluntarily recalled by the Japanese-operated company.  The company did not disclose any specific information about the...

2009-04-30 23:11:01

A drug used to treat seizures and anxiety appears to be an effective for restless leg syndrome and helps them get more sleep, researchers in Spain say. Dr. Diego Garcia-Borreguero, director of the Sleep Research Institute in Madrid, said the 12-week study involving 58 people with restless leg syndrome had 30 people receive the drug pregabalin and the rest received placebo. Sleep studies were performed at the beginning and end of the research. The researchers found nearly two-thirds of the...

2009-04-30 11:31:22

 A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 "“ May 2, 2009. RLS affects up to one in ten people.The 12 week study involved 58 people with RLS. Of the group, 30 people received...

2009-03-31 22:46:50

The painkiller oxycodone is effective in dulling the acute discomfort of shingles, an illness that often causes agony in sufferers, U.S. researchers say. The study, published in the April issue of the journal Pain, evaluated different methods to relieve pain during a course of shingles, which many patients say is the worst they have ever experienced. Study leader Robert Dworkin of the University of Rochester Medical Center and colleagues studied 87 shingles patients in Rochester, N.Y., and...

2009-01-09 07:30:00

LONDON, RESEARCH TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). The FDA had requested that the data in a single study be reformatted. In addition,...

cf5433d33f12a6421789d7ec9ae20c6c1
2008-12-17 08:35:00

The drugs that cure epileptic seizures are known to increase the risk of suicide, and federal regulators decided Tuesday drug companies must clearly display that warning.The Food and Drug Administration made the announcement a year after the agency first said patients taking the drugs have a slightly higher risk for suicide than those taking dummy pills.One in 500 patients face an increased risk of suicidal thoughts and behavior while taking the drugs. The new warning emphasizes that risks...

2008-12-16 14:56:47

The U.S. Food and Drug Administration says it will require suicide warnings on all anti-epileptic drugs, including those used to treat other conditions. The federal agency says the warning about the risk of suicidal thoughts and suicidality will be required on all anti-epileptic drugs that are also used to treat psychiatric disorders, migraine headaches and other conditions. The warnings will appear on all prescribing information or labeling. Patients being treated with anti-epileptic drugs...

2008-11-07 15:00:21

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a March 31, 2008 decision by the District Court, which had found TAP Pharmaceutical Products Inc.'s U.S. Patent No. 4,628,098 valid and enforceable. As a result of today's decision, Teva expects to market its generic version of TAP's Prevacid(R) (Lansoprazole) Delayed Release Capsules, 15 mg and 30 mg no later than November 10, 2009, when the patent is...